FDA clears Heartvue’s cardiac image evaluation software
September 3, 2026
Heartvue.Proton is designed to streamline cardiovascular MRI evaluation.
Heartvue.Proton is designed to streamline cardiovascular MRI evaluation.
New FDA clearances expand Hamamatsu’s FDA-cleared NanoZoomer portfolio with compact benchtop and high-throughput digital pathology solutions.
Beginning October 1, 2026, hospitals using Bayesian’s continuous sepsis monitor can receive additional Medicare reimbursement for eligible inpatient cases, the first reimbursement pathway of its kind for presuspicion sepsis monitoring.
CPETWise automates and standardises CPET workflow, transforming complex physiological data into streamlined processes.
The autonomous triage system’s European market authorisation comes as AI becomes increasingly embedded into the cancer screening paradigm.
Stryker (NYSE: SYK) has announced the first clinical use of SportsSuite Vision using the mixed-reality Apple Vision Pro.
Irish medtech company reaches major regulatory milestone for AI-powered technology providing rapid, objective insights into newborn brain activity
Newly Issued Patent Covers Methods of Promoting Disc Regeneration Using Components Derived from Stimulated Fibroblasts
MiniMed (Nasdaq: MMED) today reported Street-beating first-quarter revenue, upping its full-year sales guidance as it notched an early European regulatory win.
GE HealthCare announced it has received the CE Mark for its Photonova Spectra system, a photon-counting computed tomography (PCCT) system integrated with the company’s Deep Silicon detector technology.